Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Codrituzumab in previously treated advanced HCC
NCT01507168Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2012
- Primary completion
- Aug 2015
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 2 trial of codrituzumab in hepatocellular carcinoma (HCC), sponsored by Roche. Started Feb 2012; status: completed.
02
Drugs
codrituzumab
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01507168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01507168.